EQT Seeks Up to €3 Billion From Galderma IPO
- Listing of skincare firm a key test for Europe’s IPO market
- Galderma IPO would be the biggest of the year so far
This article is for subscribers only.
EQT AB is reviving plans to take skincare business Galderma public, people with knowledge of the matter said, in what’s expected to be another key test for Europe’s market for initial public offerings.
The Swedish investment firm is studying the feasibility of listing the business as soon as after the Easter break in early April, according to the people, who asked not to be identified discussing confidential information. EQT could look to raise as much as €3 billion ($3.2 billion) from a listing, they said.